Eleonora Zamparini
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 34 publications
Clinical Images: A thorn injury, a sea-borne culprit, and a tenosynovitis dilemma.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: March 23, 2026
Optimizing dalbavancin dosing for complicated methicillin-resistant Staphylococcus aureus infections: a multicentre population pharmacokinetic study.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: March 04, 2026
Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections.
Journal: Antimicrobial agents and chemotherapy
Published: February 24, 2025
Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of Staphylococcal osteoarticular Infections?
Journal: Antibiotics (Basel, Switzerland)
Published: December 30, 2024
Epidemiology and Outcomes of Infected Non-Unions: An Observational Study at an Infectious Disease Referral Centre.
Journal: Antibiotics (Basel, Switzerland)
Published: October 20, 2024
Population Pharmacokinetics and Pharmacodynamics of Dalbavancin and C-Reactive Protein in Patients with Staphylococcal Osteoarticular Infections.
Journal: Clinical pharmacokinetics
Published: August 09, 2024
Methicillin-resistant Staphylococcus epidermidis knee prosthetic infection treatment with two-stage revision and fosfomycin-rifampin combination therapy: a case report.
Journal: Journal of medical case reports
Published: August 07, 2024
Silver-Coated Distal Femur Megaprosthesis in Chronic Infections with Severe Bone Loss: A Multicentre Case Series.
Journal: Journal of clinical medicine
Published: September 28, 2023
Pharmacokinetic and pharmacodynamic considerations for optimizing antimicrobial therapy used to treat bone and joint infections: an evidence-based algorithmic approach.
Journal: Expert opinion on drug metabolism & toxicology
Published: September 06, 2023
Incidence, associated disease burden and healthcare utilization due to Staphylococcus aureus prosthetic joint infection in European hospitals: the COMBACTE-NET ARTHR-IS multi-centre study.
Journal: The Journal of hospital infection
Published: July 14, 2023
Implementation and validation of a Bayesian method for accurately forecasting duration of optimal pharmacodynamic target attainment with dalbavancin during long-term use for subacute and chronic staphylococcal infections.
Journal: International journal of antimicrobial agents
Published: May 09, 2023
Which Patients with Chronic Periprosthetic Joint Infection Are Less Suitable to Successful Two Stage Exchange Arthroplasty Surgery? A Retrospective Clinical Trial.
Journal: Clinics and practice
Published: December 09, 2022
Last Updated: 09/26/2026